HA
CPXX

Havens Advisors’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Havens Advisors’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-56,128
Closed -$1.69M – 52
2016
Q2 		$1.69M Buy
+56,128
New +$1.14M 1.29% 27

Havens Advisors's CPXX Position: Q3 2016 in Review

Havens Advisors sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 56,128 shares — an estimated $1.69M sold.

Havens Advisors first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $1.69M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Havens Advisors reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Havens Advisors sold 56,128 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $1.69M.
  • Havens Advisors first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • Havens Advisors's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $1.69M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Havens Advisors's 13F filing for Q3 2016, filed 13 Oct 2016.